Prosecution Insights
Last updated: August 16, 2026
Application No. 18/565,339

ELECTROGRAFTED FILMS FOR DNA SYNTHESIS

Final Rejection §112
Filed
Nov 29, 2023
Priority
May 31, 2021 — CN PCT/CN2021/097127 +1 more
Examiner
WONG, EDNA
Art Unit
1795
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Nanjing Genscript Biotech Co. Ltd.
OA Round
4 (Final)
59%
Grant Probability
Moderate
5-6
OA Rounds
4m
Est. Remaining
39%
With Interview

Examiner Intelligence

Grants 59% of resolved cases
59%
Career Allowance Rate
618 granted / 1055 resolved
-6.4% vs TC avg
Minimal -19% lift
Without
With
+-19.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
46 currently pending
Career history
1090
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
43.4%
+3.4% vs TC avg
§102
14.0%
-26.0% vs TC avg
§112
38.1%
-1.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1055 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This is in response to the Amendment dated July 9, 2026. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office Action. Response to Arguments Election/Restrictions This application contains claims 10 and 22-23 (product = coated electrode) drawn to an invention nonelected with traverse in the reply filed on April 17, 2025. Claim Rejections - 35 USC § 112 Claims 44 and 50 have been rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The rejection of 44 and 50 under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, has been withdrawn in view of Applicant’s amendment. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: Claims 43-44, 46, 48-50, 58 and 60-67 define over the prior art of record because the prior art does not contain any language that teaches or suggests a method of preparing an electrode surface for oligonucleotide synthesis, comprising the steps of: (a) cleaning, (a-1) electrochemically cleaning, (b) introducing, (c) electrografting, (d) stripping and (e) performing as presently claimed, esp., the step of (a-1) electrochemically cleaning the plasma-cleaned electrode surface prior to step (b), wherein the electrochemically cleaning is performed in the presence of p-toluenesulfonic acid. Therefore, a person skilled in the art would not have been motivated to adopt the above conditions, and a prima facie case of obviousness cannot be established. CN 108774588 does not teach electrochemically cleaning wherein the electrochemically cleaning is performed in the presence of p-toluenesulfonic acid. CN 108774588 teaches a glass cleaning agent, which comprises 0.4-1 parts by mass of isomers of toluenesulfonic acid; wherein, among the isomers, the mass ratio of o-toluenesulfonic acid, p-toluenesulfonic acid and m-toluenesulfonic acid is 1/(4-9)/(2-5) [ρ [0008]]. The cleaning agent is used to wipe the glass (ρ [0020]). Response to Amendment This application is in condition for allowance except for the presence of claims 10 and 22-23 (product = coated electrode) directed to an invention non-elected with traverse in the reply filed on April 17, 2025. A complete reply to the final rejection must include cancellation of nonelected claims or other appropriate action. See MPEP § 821.01. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to EDNA WONG whose telephone number is (571) 272-1349. The examiner can normally be reached Monday-Friday, 7:00 AM- 3:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Luan Van can be reached at (571) 272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EDNA WONG/Primary Examiner, Art Unit 1795
Read full office action

Prosecution Timeline

Show 1 earlier event
May 15, 2025
Non-Final Rejection mailed — §112
Oct 01, 2025
Response Filed
Oct 23, 2025
Final Rejection mailed — §112
Jan 20, 2026
Request for Continued Examination
Jan 27, 2026
Response after Non-Final Action
Apr 10, 2026
Non-Final Rejection mailed — §112
Jul 09, 2026
Response Filed
Aug 05, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12680177
METHOD OF PRODUCING GLUCARIC ACID AND METHOD OF MANUFACTURING SYNTHETIC RESIN RAW MATERIAL BY ELECTROCHEMICAL TREATMENT
2y 2m to grant Granted Jul 14, 2026
Patent 12674243
METHOD FOR MANUFACTURING CHROMIUM OXIDE COATED TINPLATE
4y 10m to grant Granted Jul 07, 2026
Patent 12668885
METHOD FOR PRODUCING ALKALI METAL ALCOHOLATES IN AN ELECTROLYSIS CELL
2y 4m to grant Granted Jun 30, 2026
Patent 12668888
COMPOSITION FOR TIN OR TIN ALLOY ELECTROPLATING COMPRISING A PYRAZOLE-TYPE ANTIOXIDANT
2y 2m to grant Granted Jun 30, 2026
Patent 12655534
ANODE WITH METALLIC INTERLAYER FOR ELECTRODEPOSITION
1y 6m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
59%
Grant Probability
39%
With Interview (-19.2%)
3y 1m (~4m remaining)
Median Time to Grant
High
PTA Risk
Based on 1055 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month